BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+27.77%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$8.73B
AUM Growth
+$8.73B
(+21%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
234
New
17
Increased
81
Reduced
66
Closed
12
Top Buys
| 1 |
Biogen
BIIB
|
$136M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$65.8M |
| 3 |
Mersana Therapeutics
MRSN
|
$51.3M |
| 4 |
Arvinas
ARVN
|
$46.7M |
| 5 |
AbbVie
ABBV
|
$36.3M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$154M |
| 2 |
Halozyme
HALO
|
$60.8M |
| 3 |
Pacific Biosciences
PACB
|
$57.2M |
| 4 |
CareDx
CDNA
|
$55.9M |
| 5 |
Charles River Laboratories
CRL
|
$52M |
Sector Composition
| 1 | Healthcare | 95.9% |
| 2 | Technology | 0.6% |
| 3 | Industrials | 0.33% |
| 4 | Financials | 0.11% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elevance Health
ELV
$72.3B
| $108M | 1.23% |
335,793
-13,330
| -4% | -$4.28M |
|
27
UnitedHealth
UNH
$277B
| $107M | 1.23% |
306,045
-18,008
| -6% | -$6.32M |
|
28
Humana
HUM
$37.7B
| $97.3M | 1.11% |
237,067
-6,929
| -3% | -$2.84M |
|
29
Insulet
PODD
$24B
| $86.3M | 0.99% |
337,468
+67,593
| +25% | +$17.3M |
|
30
Cigna
CI
$80.2B
| $86M | 0.99% |
413,208
+77,471
| +23% | +$16.1M |
|
31
Stryker
SYK
$148B
| $82.8M | 0.95% |
338,015
+15,244
| +5% | +$3.74M |
|
32
Becton Dickinson
BDX
$54.1B
| $82M | 0.94% |
327,756
+66,910
| +26% | +$16.7M |
|
33
Boston Scientific
BSX
$158B
| $79.4M | 0.91% |
2,209,859
+323,562
| +17% | +$11.6M |
|
34
DexCom
DXCM
$30.8B
| $78.9M | 0.9% |
213,307
+91,602
| +75% | +$33.9M |
|
35
Edwards Lifesciences
EW
$47.4B
| $75.4M | 0.86% |
826,918
-900
| -0.1% | -$82.1K |
|
36
Centene
CNC
$14.6B
| $71.1M | 0.81% |
1,185,047
+151,400
| +15% | +$9.09M |
|
37
Hologic
HOLX
$14.7B
| $66.2M | 0.76% |
908,588
+211,608
| +30% | +$15.4M |
|
38
Generation Bio
GBIO
$40.4M
| $66.1M | 0.76% |
2,333,180
+453,180
| +24% | +$12.8M |
|
39
Nektar Therapeutics
NKTR
$540M
| $65.7M | 0.75% |
3,866,258
+233,900
| +6% | +$3.98M |
|
40
Jazz Pharmaceuticals
JAZZ
$7.96B
| $64.2M | 0.74% |
388,865
+32,515
| +9% | +$5.37M |
|
|
HRC
41
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $63.9M | 0.73% |
652,525
+81,456
| +14% | +$7.98M |
|
42
HCA Healthcare
HCA
$95.3B
| $60.4M | 0.69% |
367,044
+21,959
| +6% | +$3.61M |
|
43
Align Technology
ALGN
$9.52B
| $60.3M | 0.69% |
112,768
+28,133
| +33% | +$15M |
|
|
MTEM
44
DELISTED
Molecular Templates, Inc.
MTEM
| $60.2M | 0.69% |
6,412,331
+1,390,335
| +28% | +$13.1M |
|
45
Exelixis
EXEL
$9.96B
| $59.1M | 0.68% |
2,944,500
-129,000
| -4% | -$2.59M |
|
46
Relay Therapeutics
RLAY
$703M
| $58.6M | 0.67% |
1,409,357
+109,357
| +8% | +$4.54M |
|
|
AXNX
47
DELISTED
Axonics, Inc. Common Stock
AXNX
| $58.4M | 0.67% |
1,168,978
+524,034
| +81% | +$26.2M |
|
48
Inspire Medical Systems
INSP
$2.5B
| $56.3M | 0.64% |
299,217
+26,234
| +10% | +$4.93M |
|
|
GWPH
49
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $54.5M | 0.62% |
472,389
-90,554
| -16% | -$10.5M |
|
50
Medtronic
MDT
$118B
| $54M | 0.62% |
461,258
-370,192
| -45% | -$43.4M |
|